Shell Asset Management CO Travere Therapeutics, Inc. Transaction History
Shell Asset Management CO
- $2.9 Billion
- Q2 2025
A detailed history of Shell Asset Management CO transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 5,398 shares of TVTX stock, worth $84,532. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,398
Previous 5,978
9.7%
Holding current value
$84,532
Previous $107,000
25.23%
% of portfolio
0.0%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding TVTX
# of Institutions
240Shares Held
101MCall Options Held
1.79MPut Options Held
555K-
Armistice Capital, LLC New York, NY8.87MShares$139 Million2.42% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$120 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X07.53MShares$118 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.01MShares$78.5 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C34.8MShares$75.1 Million0.11% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...